Overview
Irene Barbazetto is an Ophthalmologist practicing medicine in New York, New York.
Dr. Barbazetto is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).
She is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
950 3rd Ave Fl 3, New York, NY 10022
460 Park Ave Fl 5, New York, NY 10022
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David S Chu MD
Mark Kupersmith is an Ophthalmologist practicing medicine in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy.
New York Eye Surgery Associates PLLC
Nathan Radcliffe is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Radcliffe is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.
Vitreous Retina Macula Consultants Of New York
Richard Spaide is an Ophthalmologist practicing medicine in New York, New York. Dr. Spaide is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.
Frequently Asked Questions about Dr. Irene Barbazetto
How do I make an appointment with Dr. Irene Barbazetto?
You can book an appointment with Dr. Irene Barbazetto by calling their office at 212-861-9797. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Irene Barbazetto a top-rated expert for Central Serous Chorioretinopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Irene Barbazetto is classified as an Distinguished expert for Central Serous Chorioretinopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Irene Barbazetto specialize in?
While Dr. Irene Barbazetto is a Ophthalmology, they have specific expertise in Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Irene Barbazetto participate in research or clinical trials?
Yes. Dr. Irene Barbazetto has published 25 articles and abstracts on conditions like Central Serous Chorioretinopathy. You can view a list of Dr. Irene Barbazetto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Irene Barbazetto accept my insurance?
Dr. Irene Barbazetto accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-861-9797 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Barbazetto isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Central Serous ChorioretinopathyDr. Barbazetto isDistinguished. Learn about Central Serous Chorioretinopathy.
- Late-Onset Retinal DegenerationDr. Barbazetto isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Advanced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Cone DystrophyDr. Barbazetto isAdvanced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Barbazetto isAdvanced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Barbazetto isAdvanced. Learn about Doyne Honeycomb Retinal Dystrophy.
- Geographic AtrophyDr. Barbazetto isAdvanced. Learn about Geographic Atrophy.
- Experienced
- Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
- CataractDr. Barbazetto isExperienced. Learn about Cataract.
- Choroid Plexus CarcinomaDr. Barbazetto isExperienced. Learn about Choroid Plexus Carcinoma.
- Coats DiseaseDr. Barbazetto isExperienced. Learn about Coats Disease.
- Conjunctivitis (Pink Eye)Dr. Barbazetto isExperienced. Learn about Conjunctivitis (Pink Eye).
- Diabetic RetinopathyDr. Barbazetto isExperienced. Learn about Diabetic Retinopathy.